|
|
Post by peppy on Sept 12, 2017 19:32:02 GMT -5
So if we cross the 200 day avg, get label change and get scripts over 500 a week. Maybe sp will really take off? Or is financing going to hold us back?There seems to be some sort of bet, that financing will be figured out soon. In connection with the Certificate, the Company elected to defer the payment of principal on the Tranche 4 Notes from August 31, 2017 to October 31, 2017. Per the terms of the Deerfield Amendment, the Company’s obligation under the Facility Agreement to maintain at least $25 million in cash as of the end of each quarter has been reduced to $10 million as of the last day of each month through October 31, 2017 and on December 31, 2017. Good point. The orchestra maestro, get's label change, get's scripts over 500 and announces financing. all in the next 45 days.
|
|
|
|
Post by shake34 on Sept 12, 2017 19:48:00 GMT -5
Im just happy I went from newbie to lab rat today.
|
|
|
|
Post by centralcoastinvestor on Sept 12, 2017 20:23:13 GMT -5
Im just happy I went from newbie to lab rat today. Congratulations. Remember, it's important to celebrate the little things.  |
|
|
|
Post by akemp3000 on Sept 12, 2017 20:52:08 GMT -5
Seriously? Is any long invested in MNKD concerned with crosses, candlesticks or any historical technicals? Have any of the most famous investors of all time EVER quoted technical charts as the reason for their success? I'm not saying technicals are not of value because they are but this is quite simple. Afrezza works spectacularly and has the potential to improve the world of diabetes management forever...if the truth finds its way to diabetics. At the same time, the company is almost out of cash and needs to explain how they're going to extend the runway to earn the opportunity to succeed. If you believe this is a lost cause, find another stock. If you believe good drugs always win, then load up. It's only difficult if you're a trader, an analyst or a geek. I really hope I haven't offended technical friends on this board whose opinions I truly respect. I just felt the need to get this off my chest following a tall vodka ginger  |
|
|
|
Post by mytakeonit on Sept 12, 2017 21:18:55 GMT -5
I pretty much agree, but actually, I do understand much of peppy's charts. Maybe not in total detail, but trend analysis is always important. AND, you should also note that you should NEVER LOVE a stock.
??? Unless it is MNKD.
|
|
|
|
Post by akemp3000 on Sept 12, 2017 21:46:45 GMT -5
Yep. I do love MNKD. For the record, aside from my brief and rare rant, I really do enjoy and respect Peppy's analysis and posts and believe they are of great value. I guess I just wish the market was honorable and fair which would make it easier, but, since we know it's not, we take what we learn and keep moving forward. Maybe Peppy's perspective is right in that technical analysis overrides some of the corruption and might be a better way to play the game...
|
|
|
|
Post by kite on Sept 12, 2017 23:39:43 GMT -5
Im just happy I went from newbie to lab rat today. Congratulations. Remember, it's important to celebrate the little things. Congratulations fellow Lab Rat! |
|
|
|
Post by dreamboatcruise on Sept 13, 2017 0:51:51 GMT -5
Seriously? Is any long invested in MNKD concerned with crosses, candlesticks or any historical technicals? Have any of the most famous investors of all time EVER quoted technical charts as the reason for their success? I'm not saying technicals are not of value because they are but this is quite simple. Afrezza works spectacularly and has the potential to improve the world of diabetes management forever...if the truth finds its way to diabetics. At the same time, the company is almost out of cash and needs to explain how they're going to extend the runway to earn the opportunity to succeed. If you believe this is a lost cause, find another stock. If you believe good drugs always win, then load up. It's only difficult if you're a trader, an analyst or a geek. I really hope I haven't offended technical friends on this board whose opinions I truly respect. I just felt the need to get this off my chest following a tall vodka ginger What if you believe something between... not a lost cause but not a sure bet, good drugs can sometimes win (before money runs out) but not always? The world isn't always binary. |
|
|
|
Post by peppy on Sept 13, 2017 5:50:07 GMT -5
|
|
|
|
Post by sportsrancho on Sept 13, 2017 7:05:37 GMT -5
There is a lot of gray area right now.
But sitting on the fence to long gets you no where:-) Charts for me, tell me when to buy and hold. Or sell and wait for a better entry.
Look at the 10 year chart. That tells me where we are going....which looks to be $28. Drawing a trend line. (We could never hold the spikes) To get beyond that we need another drug in the pipeline and a partner with 300+ reps to help us sell Afrezza.
We need the money issue to be cleared up. And 3 quarters of sales projections under the belt that beat. And we could be valued at 2-3b again.
|
|
|
|
Post by peppy on Sept 13, 2017 7:23:47 GMT -5
I am eying the 200 week sma.
6 dollars first and it should be fast.
|
|
|
|
Post by joeypotsandpans on Sept 13, 2017 7:36:54 GMT -5
There is a lot of gray area right now. But sitting on the fence to long gets you no where:-) Charts for me, tell me when to buy and hold. Or sell and wait for a better entry. Look at the 10 year chart. That tells me where we are going....which looks to be $28. Drawing a trend line. (We could never hold the spikes) To get beyond that we need another drug in the pipeline and a partner with 300+ reps to help us sell Afrezza. We need the money issue to be cleared up. And 3 quarters of sales projections under the belt that beat. And we could be valued at 2-3b again. So funny you mention "gray area".....I was about to write there are those that are fine with watching things play out in black and white, and those that prefer to watch in color . Some take an investment and buy and hold, some trade, and some do both and some that find a picture is worth a thousand words or as I mentioned in another thread with the pics of the person in range on a regular basis using Afrezza, a picture may help save millions of lives. Perspective vs. reality and possibly both at the same time...in MNKD's particular case some may find TA fascinating with regards to how it trades over a long term basis and using the charts as a smoothing mechanism pre & post split on a visual basis. Speaking of smoothing mechanisms what I was watching yesterday was that we were trading up to and "negotiating/testing" the 200 day EMA at the $2.20 area....the exponential moving avg. is used by some as more indicative of recent price trend action as it is more weighted to recent moves, again goes back to everyone is looking at different things from their own perspectives okay now that I got that off my chest, let me grab another cup of coffee |
|
|
|
Post by kbrion77 on Sept 13, 2017 7:37:44 GMT -5
There is a lot of gray area right now. But sitting on the fence to long gets you no where:-) Charts for me, tell me when to buy and hold. Or sell and wait for a better entry. Look at the 10 year chart. That tells me where we are going....which looks to be $28. Drawing a trend line. (We could never hold the spikes) To get beyond that we need another drug in the pipeline and a partner with 300+ reps to help us sell Afrezza. We need the money issue to be cleared up. And 3 quarters of sales projections under the belt that beat. And we could be valued at 2-3b again. They need to make the move that you look back 5 years from now and say that was the moment that shifted the momentum and they never looked back. I just don't think that can happen without some type of dilution. Their pipeline is too infant for solid upfront money at this stage. A sale/lease back is a bit risky in my eyes because they would be giving up control over their facility. This label change needs to be a game changer. |
|
|
|
Post by peppy on Sept 13, 2017 7:49:28 GMT -5
There is a lot of gray area right now. But sitting on the fence to long gets you no where:-) Charts for me, tell me when to buy and hold. Or sell and wait for a better entry. Look at the 10 year chart. That tells me where we are going....which looks to be $28. Drawing a trend line. (We could never hold the spikes) To get beyond that we need another drug in the pipeline and a partner with 300+ reps to help us sell Afrezza. We need the money issue to be cleared up. And 3 quarters of sales projections under the belt that beat. And we could be valued at 2-3b again. So funny you mention "gray area".....I was about to write there are those that are fine with watching things play out in black and white, and those that prefer to watch in color . Some take an investment and buy and hold, some trade, and some do both and some that find a picture is worth a thousand words or as I mentioned in another thread with the pics of the person in range on a regular basis using Afrezza, a picture may help save millions of lives. Perspective vs. reality and possibly both at the same time...in MNKD's particular case some may find TA fascinating with regards to how it trades over a long term basis and using the charts as a smoothing mechanism pre & post split on a visual basis. Speaking of smoothing mechanisms what I was watching yesterday was that we were trading up to and "negotiating/testing" the 200 day EMA at the $2.20 area....the exponential moving avg. is used by some as more indicative of recent price trend action as it is more weighted to recent moves, again goes back to everyone is looking at different things from their own perspectives okay now that I got that off my chest, let me grab another cup of coffee I put exponential lines on the daily chart. stockcharts.com/h-sc/ui?s=MNKD&p=D&b=5&g=0&id=p26941319535
Up targets, $2.29 last months high, through that $2.35 targets. Through $2.35, $2.75. (taken off the wedge, using the weekly)
|
|
|
|
Volume too
Sept 13, 2017 7:52:21 GMT -5
via mobile
Post by sportsrancho on Sept 13, 2017 7:52:21 GMT -5
There is a lot of gray area right now. But sitting on the fence to long gets you no where:-) Charts for me, tell me when to buy and hold. Or sell and wait for a better entry. Look at the 10 year chart. That tells me where we are going....which looks to be $28. Drawing a trend line. (We could never hold the spikes) To get beyond that we need another drug in the pipeline and a partner with 300+ reps to help us sell Afrezza. We need the money issue to be cleared up. And 3 quarters of sales projections under the belt that beat. And we could be valued at 2-3b again. They need to make the move that you look back 5 years from now and say that was the moment that shifted the momentum and they never looked back. I just don't think that can happen without some type of dilution. Their pipeline is too infant for solid upfront money at this stage. A sale/lease back is a bit risky in my eyes because they would be giving up control over their facility. This label change needs to be a game changer. It does need to be a game changer. With that maybe a partner. What if we didn't sell the facility but leased part of it until we needed it? |
|
